The Earnout Trap: How Contingent Consideration in Startup M&A Can Cost You Millions

What Is an Earnout—and Why Buyers Love Them

When you sign an acquisition agreement, the headline number feels like the finish line. But if your deal includes an earnout—contingent consideration that pays out only if the business hits post-closing performance targets—that "finish line" is really just the starting gate. The buyer pays you a portion of the purchase price upfront and promises the rest later, contingent on metrics you may no longer control.

Earnouts have become a staple of startup M&A, particularly in AI and tech acquisitions where buyers and sellers often disagree on forward-looking valuations. According to SRS Acquiom's 2025 M&A Deal Terms Study, which analyzed over 2,200 private-target acquisitions worth $505 billion, earnouts remained slightly above their historical norm of approximately 20% of non-life-sciences deals. In technology transactions specifically, earnout portions can represent 20% or more of total deal value, and in some deals we've seen, 30–50%.

The pitch is seductive: "We'll bridge the valuation gap. You'll get your full price if the business performs." But here's what buyers know and founders often miss: earnout structures are designed with multiple layers of discretion that tilt the odds toward paying less. A Delaware Court of Chancery observation captures the pattern: "In what is an all-too-predictable pattern in these transactions, the parties later become embroiled in a seemingly intractable dispute regarding whether the earn-out targets were satisfied."

If you're a founder negotiating an exit, understanding how earnout structures work—and where the traps are buried—can be the difference between collecting your full purchase price and walking away with a fraction of what you were promised.

How Earnout Milestones Are Structured

Earnout milestones fall into two broad categories: financial metrics and operational milestones. Each carries distinct risks for sellers.

Financial Metrics: Revenue, ARR, EBITDA

The most common financial metrics are revenue, annual recurring revenue (ARR), EBITDA, and net operating income. As Davis Wright Tremaine notes, revenue-based earnouts are the simplest to calculate and the hardest for a buyer to manipulate—because revenue is a top-line number that doesn't depend on discretionary cost allocations. EBITDA and NOI, on the other hand, require the parties to agree on detailed accounting definitions: which expenses are included, how overhead is allocated, and whether extraordinary items are excluded. The more complex the metric, the more discretion the buyer has to influence the outcome through spending decisions and expense allocations that weren't contemplated at signing.

For SaaS and AI startups, ARR-based earnouts are common. But ARR calculations can be gamed too—if the buyer bundles your product into a larger platform sale, is that "your" ARR or the buyer's? Without clear definitions, the buyer's interpretation will usually prevail.

Operational Milestones: Product Launches, Regulatory Approvals, Customer Retention

Non-financial milestones include product launch deadlines, regulatory approvals (especially in health tech), patent issuance, or customer retention targets. These may seem straightforward, but they introduce a different problem: you're depending on the buyer to do something—develop the product, pursue the approval, maintain the customer relationship—and the buyer controls whether and how that happens.

In Fortis Advisors LLC v. Johnson & Johnson, the Delaware Court of Chancery found that J&J had breached its obligation to use "commercially reasonable efforts" to obtain regulatory approvals for two medical devices that served as earnout milestones. The court noted that "it is obvious from the record that J&J's efforts toward the iPlatform regulatory milestones were not commercially reasonable." The case illustrates that even when buyers are contractually obligated to pursue milestones, founders may need to litigate to enforce those obligations—and litigation is expensive, slow, and uncertain.

The Measurement Period Traps

Even if your milestones are clearly defined, the measurement period introduces its own set of traps. Here are the three we see most often:

1. Fiscal Year Misalignment

If the buyer's fiscal year doesn't align with your historical reporting periods, the earnout calculation may capture a partial period that doesn't reflect the business's true performance cycle. A SaaS company with seasonal booking patterns, for example, may see distorted metrics if the measurement period starts mid-quarter. Always negotiate measurement periods that align with your historical fiscal calendar.

2. Buyer's Accounting Methodology

After closing, the buyer controls the accounting. If the earnout is based on EBITDA or NOI, the buyer can change accounting methods, reallocate overhead, or reclassify expenses in ways that reduce the measured metric. A well-drafted earnout should require the buyer to apply GAAP "consistent with the target company's historical practices" and should specify which expenses are included or excluded. Without this lock-in, the buyer's accounting choices can systematically erode your earnout.

3. "Gate" Provisions

Some earnout structures include gate provisions—conditions that must be satisfied before the earnout is calculated at all. For example, the buyer may require that the acquired business be "operated as a standalone unit" to trigger the earnout, but then integrate the business into its broader operations, making standalone measurement impossible. In Fortis Advisors, LLC v. Dematic Corp., the Delaware Supreme Court addressed a dispute over whether "Company Products" included the seller's standalone software or pieces of code integrated into the buyer's platform—a definitional ambiguity that led to litigation. The lesson: if integration will occur, the earnout formula must account for it explicitly.

Operating Restrictions: You Can't Control What You Need to Hit

This is the core paradox of earnouts: the seller's payout depends on business performance, but the buyer controls the business. After closing, you lose operational control. The buyer decides hiring, spending, product roadmap, customer relationships, and strategic priorities—all of which directly affect whether your earnout targets are achievable.

Delaware courts have developed a body of law around "best efforts" and "commercially reasonable efforts" clauses that are supposed to protect sellers. As Hughes Hubbard explains, these provisions fall into two categories: "outward-facing" standards (which compare the buyer's efforts to an industry benchmark—generally seller-friendly) and "inward-facing" standards (which compare the buyer's efforts to its own past practices—generally buyer-friendly).

In SRS v. Alexion Pharmaceuticals, the Delaware Court of Chancery awarded approximately $130 million in damages to former stockholders after finding that Alexion had breached its obligation to use "commercially reasonable efforts" to develop an earnout-milestone drug. The court found that Alexion's pursuit of an idiosyncratic "10 by 2023" product-launch initiative—and AstraZeneca's subsequent decision to terminate the project for merger synergies—were not actions a "hypothetical typical company" would have taken.

But in STX Business Solutions v. Financial Information Technologies, the court granted the buyer's motion to dismiss because the merger agreement gave the buyer "broad discretion to run the business so long as the Buyer did not take action in bad faith or with the specific intention of causing a reduction in the Earnout." The court held that "a party does not act in bad faith by relying on contract provisions for which that party bargained where doing so simply limits advantages to another party." In other words, if you negotiate a buyer-friendly efforts clause, the buyer can make business decisions that suppress your earnout—so long as it didn't act with "specific intention" to harm you.

The practical takeaway: the effort standard you negotiate at signing determines your leverage post-closing. "Commercially reasonable efforts" tied to an external industry benchmark gives you far more protection than "good faith" or "business judgment" standards.

Earnout Dispute Resolution—and Why It Can Favor Buyers

Most earnout provisions include a dispute resolution mechanism: the buyer delivers its earnout calculation, the seller has a review period (typically 30–60 days) to object, and unresolved disputes go to a neutral third-party accounting firm. This framework sounds fair, but several structural features tilt it toward buyers.

First, the buyer prepares the initial calculation. The seller must then identify and object to specific items within a compressed review window—often without full access to the buyer's internal financial systems. Second, the independent accountant's review is typically limited to the specific items in dispute, not a de novo review of the entire calculation. If the seller misses an issue during the objection period, it may be waived. Third, the accountant's determination is usually binding "absent manifest error"—a high bar for reversal.

In AM Buyer, LLC v. Argosy Investment Partners IV, L.P., the Delaware Supreme Court affirmed that an independent accountant's earnout EBITDA calculation was "final, conclusive, and binding" and reviewable only for fraud or "clear and manifest error." The court enforced the contractual dispute resolution framework even though the buyer challenged the accountant's conclusions. This case shows that once you submit to an independent accountant's jurisdiction, overturning the result is extremely difficult.

Some agreements mandate arbitration rather than litigation. While arbitration can be faster, it also limits discovery, appeal rights, and the ability to develop a full factual record—all of which can disadvantage the party trying to prove the buyer manipulated metrics.

Tax Treatment of Contingent Consideration

The tax treatment of earnout payments is often an afterthought during negotiations, but it can significantly affect your net proceeds. The key question is whether earnout payments qualify for installment method treatment under IRC Section 453, which allows you to defer recognizing gain until payments are actually received.

Under Section 453, an "installment sale" is a disposition of property where at least one payment is received after the close of the taxable year in which the disposition occurs. If your earnout payments are structured as deferred purchase price—not as compensation for post-closing services—you may be able to spread the tax liability over the payment period. IRS Publication 537 covers the mechanics of installment sale reporting, including how to handle contingent payments where the total selling price isn't known at closing.

However, several traps exist. If you elect out of the installment method—or if the earnout is characterized as compensation for services rather than purchase price—you may owe tax on the entire contingent amount upfront, before you've received it. As DarrowEverett explains, the distinction between deferred purchase price and compensation for services is not always clear, and the characterization affects both timing and character of the income (capital gains vs. ordinary income).

Another risk: constructive receipt. If the earnout is placed in an escrow or escrow-like arrangement that you could access, the IRS may take the position that you've constructively received the payment, triggering immediate tax liability. Structuring the earnout as a true contingent obligation—not a guaranteed payment held in escrow—is essential to preserve installment treatment.

For stock-for-stock deals with earnout components, the analysis becomes even more complex. If the contingent consideration is paid in buyer stock, the timing of recognition and the character of the gain may differ from cash earnouts. Always involve a tax advisor early in the negotiation—not after signing.

Negotiation Strategies: Protecting Your Earnout

If an earnout is unavoidable—sometimes it's the only way to bridge a valuation gap—here are the protections we recommend founders negotiate:

1. Shorter Measurement Periods

The longer the earnout period, the more time the buyer has to integrate, restructure, or deprioritize your business. SRS Acquiom's 2025 study found that earnout performance periods shortened in 2024, with none exceeding four years. Push for one to two years maximum. Shorter periods reduce both the buyer's opportunity to influence outcomes and your exposure to integration disruption.

2. Floor Payments and Minimum Guaranteed Consideration

Negotiate a floor—a minimum earnout payment that's guaranteed regardless of performance. This converts part of the contingent consideration into certain consideration and shifts risk back to the buyer. Even a 50% floor dramatically improves your downside protection compared to an all-or-nothing structure.

3. Scaled or Tiered Earnout Structures

Scaled earnouts—where partial achievement triggers partial payments—are more favorable than binary structures where the full amount is paid only if the target is met and nothing is paid if it falls short by even one dollar. Tiered structures reduce the cliff effect and give you partial recovery even if the business narrowly misses targets.

4. True-Up Provisions

A true-up provision requires the buyer to reconcile its earnout calculations against agreed-upon accounting standards and historical practices. This gives you a contractual basis to challenge adjustments that deviate from the target company's past accounting methodology. Pair this with a requirement that the buyer maintain separate books and records for the acquired business during the earnout period—so you can actually audit the numbers.

5. Operating Covenants with External Benchmarks

Negotiate operating covenants that require the buyer to run the business "in the ordinary course consistent with past practices" and to use "commercially reasonable efforts" defined by reference to industry standards, not the buyer's own past practices. As the Delaware case law shows, outward-facing standards give you a meaningful benchmark to enforce; inward-facing standards give the buyer cover for almost any decision.

6. Acceleration Triggers

Include acceleration clauses that cause the full earnout (or a specified portion) to become immediately payable if: (a) the buyer sells the business during the earnout period, (b) the buyer materially breaches its operating covenants, or (c) the buyer takes actions that make it impossible to calculate the earnout. Acceleration provisions prevent the buyer from "earning" a discount by disrupting the business and then claiming the targets weren't met.

7. Separation of Earnout from Integration Decisions

If the buyer plans to integrate your product into its platform, the earnout formula must account for that integration. Negotiate provisions that attribute revenue or metrics from integrated products back to the earnout calculation—or that accelerate the earnout if integration makes standalone measurement impossible. Without this, the buyer can integrate, obscure your contribution, and argue the targets weren't hit.

8. Seller Access Rights During the Earnout Period

Negotiate express rights to access the buyer's financial records, personnel, and systems during the review period after each measurement period. The provision should grant the seller access to the buyer's books and records and key personnel—not just a summary calculation. Without access, you can't meaningfully challenge the buyer's numbers.

Why 2025–2026 Makes This Urgent

AI startup acquisitions in 2025–2026 are heavily using earnouts to bridge valuation gaps between projected and actual revenue. Buyers are increasingly skeptical of forward-looking projections—especially for pre-revenue or early-revenue AI companies—and earnouts let them defer payment until the revenue materializes. This means more founders are signing deals where 20–50% of their purchase price is contingent on performance they won't control.

If you're considering an acquisition offer that includes an earnout, the time to negotiate protections is before signing. After closing, your leverage evaporates. For more on the broader M&A landscape, see our coverage of M&A due diligence for AI products and the AI diligence workstream most buyers aren't running yet. You may also want to understand how reps and warranties insurance interacts with your deal structure.

Actionable Next Steps

1. Model the worst case. Before you agree to an earnout, model what happens if the business achieves 50% of targets. If that number doesn't work for your cap table, don't sign.
2. Get the definitions right. Insist on precise definitions of every earnout metric, accounting methodology, measurement period, and effort standard. Ambiguity favors the buyer—always.
3. Negotiate floors and acceleration. A minimum guaranteed payment and acceleration triggers are your insurance policy against buyer-induced underperformance.
4. Involve a tax advisor early. The installment method can save you significant tax liability, but only if the earnout is structured correctly from the start. Don't wait until after closing to discover you've lost deferral.
5. Plan for the dispute. Assume the earnout will be disputed. Negotiate seller access rights, external benchmarks for effort obligations, and a dispute resolution mechanism that gives you a fair shot—not one that defaults to the buyer's calculation.